| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Mri To Lead Growth In Medical-imaging Market
Posted on 11/01/2007 16:10 PM | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
The U.S. medical-imaging market — including ultrasound, magnetic resonance imaging (MRI), radiography and mammography, and computed tomography (CT) — will be worth an estimated $11.4 billion by 2012, according to a new report by BCC Research, Medical Imaging: Equipment and Related Products.
CT currently accounts for the largest share of the market — worth an estimated $2.3 billion in 2007 — and is predicted to top $3.2 billion by 2012.
But MRI scanners, now with the second-most market share, are the fastest-growing segment, with a projected CAGR of 9.8 percent. Currently valued at over $1.8 billion, the MRI scanner market is expected to exceed $2.8 billion in 2012.
The third-largest segment, ultrasound equipment, is currently valued at $1.6 billion and is expected to grow with a CAGR of 6.9 percent to $2.3 billion in 2012.
Radiography and mammography equipment also is expected to experience significant growth, from a current value of $1.3 billion in 2007 to nearly $2 billion in 2012.
And positron emission tomography (PET) scanners, including combination PET/CT machines, are expected to grow from $669.8 million this year to $991.0 million in 2012.
On Tuesday, two leading diagnostic-imaging companies — E-Z-EM (EZEM), of Lake Success, NY, and Bracco Diagnostics, the U.S. subsidiary of Milan, Italy-based Bracco Imaging — announced plans to merge. Bracco will acquire all of the outstanding shares of E-Z-EM, in a cash transaction valued at $241 million.
E-Z-EM manufacturers contrast agents for gastrointestinal radiology. Products include VoLumen, a patent-pending, low-density barium sulfate suspension for use as an oral contrast in multi-detector CT and PET/CT studies. The company also makes Empower, the first family of CT injectors on the market with patented EDA technology for detecting contrast extravasation.
Med Tech Sentinel is a regular contributor to BioHealth Investor
_________________
Med Tech Sentinel
The U.S. medical-imaging market — including ultrasound, magnetic resonance imaging (MRI), radiography and mammography, and computed tomography (CT) — will be worth an estimated $11.4 billion by 2012, according to a new report by BCC Research, Medical Imaging: Equipment and Related Products.
CT currently accounts for the largest share of the market — worth an estimated $2.3 billion in 2007 — and is predicted to top $3.2 billion by 2012.
But MRI scanners, now with the second-most market share, are the fastest-growing segment, with a projected CAGR of 9.8 percent. Currently valued at over $1.8 billion, the MRI scanner market is expected to exceed $2.8 billion in 2012.
The third-largest segment, ultrasound equipment, is currently valued at $1.6 billion and is expected to grow with a CAGR of 6.9 percent to $2.3 billion in 2012.
Radiography and mammography equipment also is expected to experience significant growth, from a current value of $1.3 billion in 2007 to nearly $2 billion in 2012.
And positron emission tomography (PET) scanners, including combination PET/CT machines, are expected to grow from $669.8 million this year to $991.0 million in 2012.
On Tuesday, two leading diagnostic-imaging companies — E-Z-EM (EZEM), of Lake Success, NY, and Bracco Diagnostics, the U.S. subsidiary of Milan, Italy-based Bracco Imaging — announced plans to merge. Bracco will acquire all of the outstanding shares of E-Z-EM, in a cash transaction valued at $241 million.
E-Z-EM manufacturers contrast agents for gastrointestinal radiology. Products include VoLumen, a patent-pending, low-density barium sulfate suspension for use as an oral contrast in multi-detector CT and PET/CT studies. The company also makes Empower, the first family of CT injectors on the market with patented EDA technology for detecting contrast extravasation.
Med Tech Sentinel is a regular contributor to BioHealth Investor
_________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
Examples
Underground Trading - Sat May 10, 2008 04:02PM
This is an update on my speculative long term position p [read more]
This is an update on my speculative long term position p [read more]
Morpheus Trading - Mon May 12, 2008 04:25AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Millionaire Now! by Larry Nusbaum - Mon May 12, 2008 04:54AM
MORNING MARKET COMMENTARYfor Monday, May 12, 2008Weak Financ [read more]
MORNING MARKET COMMENTARYfor Monday, May 12, 2008Weak Financ [read more]
<< My Home | TheMoneyBlogs Home